Literature DB >> 3541576

Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.

C S Greenberg, D V Devine, K M McCrae.   

Abstract

Recently, monoclonal antibody (DD-3B6) to fibrin D-dimer was prepared and coupled to latex beads to provide a specific test (Dimertest) for fibrinolysis. The purpose of this study was to evaluate the Dimertest assay as a clinical laboratory test for the measurement of plasma fibrin D-dimer derivatives. The Dimer-test assay specifically detected 2 micrograms/mL of purified fibrin D-dimer or fibrin D-dimer/fragment E complex added to afibrinogenemic plasma but did not detect 500 micrograms/mL of either fibrinogen fragments X, D, E, or 160 micrograms/mL cross-linked fibrinogen. The fibrin(ogen) degradation product (FDP) assays of American Dade or Wellcome Diagnostics detected 5.0 micrograms/mL of fibrin D-dimer and from 1 to 10 micrograms/mL of the other FDPs. Twenty-eight percent of 150 random plasma samples assayed from hospitalized patients were positive for fibrin D-dimer derivatives. Plasma samples from 152 patients suspected of having disseminated intravascular coagulation (DIC) were assayed for serum FDP (Wellcome Diagnostics) and plasma fibrin D-dimer derivatives. Samples from 69% of patients with serum FDP levels less than 10 micrograms/mL, and more than 90% of those with serum FDP levels greater than 10 micrograms/mL, were positive for fibrin D-dimer derivatives. Dimertest results were not modified by heparin, streptokinase, freeze-thawing, or clotting plasma. Serum fibrinogen-related antigens were immunoadsorbed from Dimer-test positive sera by anti-fibrinogen antibody and formalin-fixed Cowan I strain Staphylococcus aureus. Analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and protein blotting with the use of monoclonal antibody DD-3B6 demonstrated a protein band with similar mobility to purified D-dimer. The measurement of plasma fibrin D-dimer derivatives by the Dimertest assay is a rapid, sensitive, and specific laboratory test for fibrinolysis. The Dimertest assay has proven to be a useful addition to the clinical laboratory and should be helpful in the diagnosis and management of patients with diseases associated with fibrinolysis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3541576     DOI: 10.1093/ajcp/87.1.94

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  Monoclonal antibodies for clinical applications. Patents and literature.

Authors:  J S Dordick
Journal:  Appl Biochem Biotechnol       Date:  1988-12       Impact factor: 2.926

2.  Increased concentrations of D-dimers in newborn infants.

Authors:  I R Hudson; B E Gibson; J Brownlie; B M Holland; T L Turner; R G Webber
Journal:  Arch Dis Child       Date:  1990-04       Impact factor: 3.791

3.  Variations and clinical significance of coagulation and fibrinolysis parameters in patients with diabetes mellitus.

Authors:  J Hu; W Wei; G Din; L Yuan; Z Liu
Journal:  J Tongji Med Univ       Date:  1998

Review 4.  Laboratory evaluation of a bleeding patient.

Authors:  R O Wallerstein
Journal:  West J Med       Date:  1989-01

5.  To scan or not to scan - D-dimers and computed tomography pulmonary angiography in the era of COVID-19.

Authors:  Alexander A Tuck; Harriet L White; Badr A Abdalla; Gwendolen J Cartwright; Katherine R Figg; Emily N Murphy; Benjamin C Pyrke; Mark A Reynolds; Rana M Taha; Hasan N Haboubi
Journal:  Clin Med (Lond)       Date:  2021-02-16       Impact factor: 2.659

6.  Point of care D-dimer testing in the emergency department: a bioequivalence study.

Authors:  Shuhana Perveen; Danielle Unwin; Amith Loknath Shetty
Journal:  Ann Lab Med       Date:  2012-12-17       Impact factor: 3.464

7.  Label-Free Kinetic Studies of Hemostasis-Related Biomarkers Including D-Dimer Using Autologous Serum Transfusion.

Authors:  Heiko Rühl; Christina Berens; Anna Winterhagen; Jens Müller; Johannes Oldenburg; Bernd Pötzsch
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

Review 8.  Immunohaemostasis: a new view on haemostasis during sepsis.

Authors:  Xavier Delabranche; Julie Helms; Ferhat Meziani
Journal:  Ann Intensive Care       Date:  2017-12-02       Impact factor: 6.925

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.